Millennium Management
LYRA

Millennium Management’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Millennium Management’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-407
Closed -$5.63K – 6322
2024
Q2 		$5.63K Sell
407
-7,715
-95% -$872K ﹤0.01% 5671
2024
Q1 		$2.53M Buy
8,122
+1,602
+25% +$427K ﹤0.01% 3517
2023
Q4 		$1.71M Buy
6,520
+1,253
+24% +$227K ﹤0.01% 3732
2023
Q3 		$1.03M Buy
+5,267
New +$942K ﹤0.01% 4166
2023
Q2 		– Sell
-1,162
Closed -$120K – 6460
2023
Q1 		$120K Buy
+1,162
New +$144K ﹤0.01% 5357
2022
Q4 		– Sell
-378
Closed -$95K – 6831
2022
Q3 		$95K Sell
378
-1,396
-79% -$413K ﹤0.01% 5985
2022
Q2 		$501K Sell
1,774
-480
-21% -$131K ﹤0.01% 4954
2022
Q1 		$453K Sell
2,254
-805
-26% -$177K ﹤0.01% 5197
2021
Q4 		$667K Buy
3,059
+696
+29% +$224K ﹤0.01% 4785
2021
Q3 		$1.08M Sell
2,363
-740
-24% -$280K ﹤0.01% 4591
2021
Q2 		$1.25M Buy
+3,103
New +$1.41M ﹤0.01% 4466
2021
Q1 		– Sell
-880
Closed -$502K – 6273
2020
Q4 		$502K Buy
+880
New +$496K ﹤0.01% 4192
2020
Q3 		– Sell
-998
Closed -$566K – 4669
2020
Q2 		$566K Buy
+998
New +$730K ﹤0.01% 3329

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management's LYRA Position: Q3 2024 in Review

Millennium Management sold out of LYRA THERAPEUTICS INC (LYRA) in Q3 2024, closing a stake of 407 shares — an estimated $5.63K sold.

Millennium Management first reported a position in LYRA in Q2 2020 and held it in 13 quarters. The position peaked at $2.53M in Q1 2024. 62 funds tracked by Wall St. Rank hold LYRA as of Q3 2024.

  • Millennium Management reported no remaining LYRA THERAPEUTICS INC position as of Q3 2024 after selling out during the quarter.
  • Millennium Management sold 407 LYRA THERAPEUTICS INC shares in Q3 2024, an estimated $5.63K.
  • Millennium Management first reported a position in LYRA THERAPEUTICS INC in Q2 2020 and held it in 13 quarters.
  • Millennium Management's LYRA THERAPEUTICS INC position peaked at $2.53M in Q1 2024.
  • 62 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q3 2024.

Based on Millennium Management's 13F filing for Q3 2024, filed 14 Nov 2024.